Japan-China merger puts growth in East Asia first

Article Abstract:

Tokyo, Japan-based pharmaceutical development firm, GNI, announced a merger with Shanghai Genomics on 20 June 2005, where the new company will be involved in predicting the genome-wide effects of disturbance in gene regulation. The deal highlights the flurry of activity stemming from intensifying interest in mainland China as a locale country for biomedical research and development (R&D).

China, Acquisitions & mergers, Biotechnology industry, Mergers, acquisitions and divestments, Biotechnology industries, Company acquisition/merger

---

Japanese giants renew interest in industrial biotech

Article Abstract:

Fujifilm, producer of photographic film and digital imaging equipment, is planning to make biotech one of the main focuses of research at the research center in Kanagawa Prefecture outside Tokyo and is scheduled to begin operation in March 2006. The first segment of biotech billed to benefit from the backing of seemingly unrelated industries in Japan is industrial biotech.

United States, Photographic equipment and supplies, Strategy & planning, Science & research, Photographic studios, portrait, Photographic Services, Photography Studios, Portrait, Research, Planning, Agricultural biotechnology, Photographic industry, Company business planning, Fujifilm

---

Japanese firms broaden investment focus to early biotech

Article Abstract:

A number of deals indicate that Japanese pharmaceutical companies were increasingly willing to invest in early-stage foreign biotech ventures. The trend reflects the growing recognition of the potentional that foreign biotech R&D could supplement dwindling drug pipelines and signaled a bolder investment strategy on the part of traditionally risk-averse Japanese firms.

Financial management, Biological Product (except Diagnostic) Manufacturing, Molecular Biological Products, Company investment, Investments, Biotechnology

Similar abstracts:

• Abstracts: UK bidding war amidst merger mania. GM giants pair up to do battle. Europe responds to UK's GM field trials
• Abstracts: Are university researchers at risk for patent infringement? BioPolis report paints fractured picture of EU biotech
• Abstracts: Make sure the message gets through in an interview. Turning a published article into gold. How to get media coverage of environmental initiatives
• Abstracts: Upward trend in financing continues, but fewer feel flush. Looking at US versus European exit opportunities. Patent drop reveals pressures on industry

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.